CLAUDIN 18.2

Clinical trials for CLAUDIN 18.2 explained in plain language.

Never miss a new study

Get alerted when new CLAUDIN 18.2 trials appear

Sign up with your email to follow new studies for CLAUDIN 18.2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for hard-to-treat bile duct cancer: combo therapy shows promise

Disease control Ongoing

This study tests two drugs, candonilimab and LM-302, in people with advanced biliary tract cancer that has not responded to standard chemotherapy and immunotherapy. The goal is to see if the combination can shrink tumors or slow the disease. About 78 adults with a specific protei…

Matched conditions: CLAUDIN 18.2

Phase: PHASE1, PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control

Last updated May 17, 2026 07:58 UTC

CLAUDIN 18.2

Get alerted when new CLAUDIN 18.2 trials appear

New hope for hard-to-treat bile duct cancer: combo therapy shows promise